Sale!

Can Assist Breast Test

Original price was: $2,112.Current price is: $1,902.

-10%

The Can Assist Breast Test is a revolutionary genomic assay designed specifically for patients with ER-positive, PR-positive, HER2-negative breast cancer. This advanced test analyzes multiple gene expressions to predict recurrence risk and guide personalized treatment decisions. By evaluating 93 cancer-related genes, it provides a comprehensive molecular profile that helps oncologists determine whether chemotherapy would provide significant benefit or if hormone therapy alone would be sufficient. The test costs $1902 USD and delivers results within 15 working days, offering patients and physicians crucial information for making informed treatment choices that can potentially avoid unnecessary chemotherapy and its associated side effects.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Can Assist Breast Test: Personalized Breast Cancer Treatment Guidance

Understanding the Can Assist Breast Test

The Can Assist Breast Test represents a breakthrough in personalized cancer care, specifically designed for patients diagnosed with estrogen receptor (ER) positive, progesterone receptor (PR) positive, and HER2-negative breast cancer. This sophisticated genomic test provides crucial information that helps oncologists make informed decisions about treatment strategies, particularly regarding the necessity of chemotherapy.

Breast cancer treatment has evolved significantly, moving away from one-size-fits-all approaches toward personalized medicine. The Can Assist Breast Test plays a vital role in this evolution by analyzing the unique molecular characteristics of each patient’s tumor, enabling healthcare providers to tailor treatment plans that maximize effectiveness while minimizing unnecessary side effects.

What the Test Measures and Detects

The Can Assist Breast Test evaluates 93 cancer-related genes through advanced immunohistochemistry and genomic analysis techniques. This comprehensive assessment provides:

  • Recurrence Risk Assessment: Determines the likelihood of cancer recurrence within 5-10 years
  • Chemotherapy Benefit Prediction: Identifies whether chemotherapy would provide significant clinical benefit
  • Molecular Subtyping: Classifies tumors based on their genetic characteristics
  • Treatment Response Indicators: Provides insights into potential response to various therapeutic options

The test generates a risk score that categorizes patients into low, intermediate, or high-risk groups, helping physicians determine the most appropriate treatment pathway for each individual case.

Who Should Consider This Test

The Can Assist Breast Test is specifically recommended for patients who meet the following criteria:

  • Newly diagnosed with early-stage breast cancer
  • Confirmed ER-positive and PR-positive status
  • HER2-negative breast cancer
  • Patients facing decisions about adjuvant chemotherapy
  • Those seeking personalized treatment guidance
  • Patients wanting to avoid unnecessary chemotherapy side effects

This test is particularly valuable for patients with intermediate clinical risk factors where the benefit of chemotherapy is uncertain based on traditional assessment methods alone.

Benefits of Taking the Can Assist Breast Test

Undergoing the Can Assist Breast Test offers numerous advantages for both patients and healthcare providers:

  • Personalized Treatment Decisions: Provides data-driven insights for customized therapy plans
  • Chemotherapy Avoidance: Helps identify patients who may not benefit from chemotherapy, sparing them from unnecessary side effects
  • Improved Quality of Life: Reduces exposure to toxic treatments when not medically necessary
  • Enhanced Confidence: Gives patients and physicians greater certainty in treatment choices
  • Cost-Effective Care: Potentially reduces healthcare costs by avoiding ineffective treatments
  • Comprehensive Analysis: Provides a detailed molecular profile beyond standard pathology

Understanding Your Test Results

Your Can Assist Breast Test results will provide a comprehensive analysis that your oncologist will interpret in the context of your specific clinical situation. The test generates:

  • Risk Category: Low, intermediate, or high risk of recurrence
  • Recurrence Score: Numerical value indicating recurrence probability
  • Treatment Recommendations: Guidance on chemotherapy benefit
  • Clinical Context: How results relate to your specific cancer characteristics

It’s important to discuss your results thoroughly with your healthcare provider, who will consider the test findings alongside other clinical factors such as tumor size, grade, and lymph node status to develop your personalized treatment plan.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $1902
Regular Price $2112

Turnaround Time: Samples accepted daily by 3:30 PM; Reports delivered within 15 working days

Sample Requirements: Formalin fixed paraffin embedded tissue block shipped at room temperature

Convenient Testing Locations Across the USA

We have branches conveniently located in all major cities throughout the United States, including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our nationwide network ensures that patients can access this advanced testing regardless of their location.

Take Control of Your Breast Cancer Treatment Journey

The Can Assist Breast Test empowers you and your healthcare team with critical information to make the best possible treatment decisions. By understanding your tumor’s unique molecular characteristics, you can pursue a treatment path that’s tailored specifically to your cancer, potentially avoiding unnecessary treatments and their associated side effects.

Ready to get started? Book your Can Assist Breast Test today by calling our dedicated healthcare line at +1(267) 388-9828 or schedule your appointment through our online booking system. Our genetic counselors and healthcare professionals are available to answer your questions and guide you through the testing process.

Take the next step toward personalized breast cancer care with the Can Assist Breast Test – because your treatment should be as unique as you are.